Advanced Research Training in Immunology for Surgery Trainees (ARTIST)
外科实习生免疫学高级研究培训 (ARTIST)
基本信息
- 批准号:9292218
- 负责人:
- 金额:$ 13.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-15 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): The goal of the OSU Advanced Research Training in Immunology for Surgery Trainees (ARTIST) program is to prepare surgical residents (postdoctoral trainees) for translational research careers involving study of how immune mechanisms affect tissue injury, repair, regeneration and replacement. This program is uniquely focused, serving a need that cannot currently be met at OSUWMC or perhaps anywhere else. As such, ARTIST will be a new paradigm for study and adoption by programs at other medical colleges. ARTIST integrates Immunology didactics, research-in-progress seminars and journal clubs from the College of Medicine Biomedical Sciences Graduate Program, as well as Translational Research courses from a novel "Signature Program Translational Science Curriculum," core courses in the Masters of Medical Science Program (Research Design, Grant Writing, Research Ethics, Biostatistics), and a new "Career Development for Surgeons" course. In addition, networking opportunities and an annual program retreat will offer unique opportunities for career development. National leaders and department chairs in surgery, especially those who have first-hand experience as visiting professors, recognize the strengths of the OSU Department of Surgery's Residency and Research Training Program. A small cadre of our surgical trainees, all training grant eligible and highly diverse (~30% URM, 50% female), will be selected for ARTIST. We will also invite trainees from other academic institutions by competitive application. Trainees will dedicate two full-time years, without clinical responsibilities, towards research education and training, earning a Master's of Science in Medical Science degree. They will be prepared to apply their training to deepen understanding of the immune system, as well as developing new, immune-based diagnostics, prognostics, therapeutics and clinical approaches that are relevant to surgical procedures and outcomes. While in the program they will also learn how to develop and draw upon clinical databases that integrate surgical outcomes with data from pathology and immunology. ARTIST Faculty Trainers who lead or participate in NIH-funded Program Projects (P01) and Specialized Programs of Research Excellence (SPORE) will provide context for use of such valuable databases in cores for collaborative team science. Infrastructure for ARTIST will include relevant OSU institutional research centers, research cores, outstanding training faculty and departmental administration. ARTIST's NIH-funded faculty, with distinguished track records in immunology and translational research, have been specially selected to inspire and guide trainees in immunology-focused mentored research. Clinical co-mentors and a post-training longitudinal, career advisory committee will provide guidance and facilitate placement into prestigious fellowships and academic faculty positions for ARTIST trainees. The national impact of the ARTIST program will be realized through scientific maturation of a trainee group with comprehensive clinical expertise, with the ability to apply the power of immunology-based research to benefit surgical patients.
描述(由申请者提供):俄亥俄州立大学为外科实习生(艺术家)提供的免疫学高级研究培训计划的目标是为外科住院医师(博士后实习生)的翻译研究职业做准备,涉及研究免疫机制如何影响组织损伤、修复、再生和替换。这一计划是独一无二的,服务于目前OSUWMC或其他任何地方都无法满足的需求。因此,ARTER将成为其他医学院课程学习和采用的新范例。Artist整合了来自医学院生物医学研究生项目的免疫学教学学、正在进行的研究研讨会和期刊俱乐部,以及来自新颖的“标志性项目转化科学课程”的翻译研究课程,医学硕士项目(研究设计、拨款撰写、研究伦理学、生物统计学)的核心课程,以及新的“外科医生的职业发展”课程。此外,网络机会和年度项目务虚会将为职业发展提供独特的机会。国家外科领导和外科系主任,特别是那些有第一手客座教授经验的人,认识到俄亥俄州立大学外科系住院医师和研究培训计划的优势。我们的外科实习生中的一小部分,所有的培训资助金合格和高度多样化(约30%的URM,50%的女性)将被选为艺术家。我们亦会以竞争性申请方式,邀请其他学术机构的学员参加。学员将在没有临床责任的情况下投入两年的全职时间进行研究、教育和培训,获得医学科学硕士学位。他们将准备应用他们的培训来加深对免疫系统的了解,以及开发与手术程序和结果相关的基于免疫的新诊断、预后、治疗和临床方法。在该计划中,他们还将学习如何开发和利用临床数据库,将手术结果与病理学和免疫学数据相结合。领导或参与美国国立卫生研究院资助的项目(P01)和卓越研究专业项目(SPORT)的艺术家学院培训师将为合作团队科学核心中使用这些有价值的数据库提供背景。艺术家的基础设施将包括相关的俄亥俄州立大学机构研究中心、研究中心、优秀的培训教师和部门管理。艺术家的NIH资助的教师,在免疫学和翻译研究方面有着杰出的记录,已经被特别挑选出来,以激励和指导学员进行以免疫学为重点的指导性研究。临床联合导师和培训后的纵向职业咨询委员会将为艺术家实习生提供指导,并促进他们进入著名的研究员和学术教员职位。ARTER计划的全国影响力将通过一个具有全面临床专业知识的受训人员群体的科学成熟来实现,该受训人员群体有能力应用基于免疫学的研究力量来造福手术患者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GINNY L BUMGARDNER其他文献
GINNY L BUMGARDNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GINNY L BUMGARDNER', 18)}}的其他基金
CTSA Predoctoral T32 at the Ohio State University
俄亥俄州立大学 CTSA 博士前 T32
- 批准号:
10705448 - 财政年份:2023
- 资助金额:
$ 13.27万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10681215 - 财政年份:2021
- 资助金额:
$ 13.27万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10270657 - 财政年份:2021
- 资助金额:
$ 13.27万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10430249 - 财政年份:2021
- 资助金额:
$ 13.27万 - 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
- 批准号:
10438948 - 财政年份:2021
- 资助金额:
$ 13.27万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10203783 - 财政年份:2019
- 资助金额:
$ 13.27万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10436921 - 财政年份:2019
- 资助金额:
$ 13.27万 - 项目类别:
Investigating a Novel Cellular Therapy to Prevent and Treat Acute Antibody Mediated Kidney Transplant Rejection
研究预防和治疗急性抗体介导的肾移植排斥反应的新型细胞疗法
- 批准号:
10653007 - 财政年份:2019
- 资助金额:
$ 13.27万 - 项目类别:














{{item.name}}会员




